Primary central nervous system lymphoma

HA Fine, RJ Mayer - Annals of internal medicine, 1993 - acpjournals.org
Objective: To compare the pathogenesis, clinical presentation, therapy, and prognosis of
primary central nervous system lymphoma in immunocompetent persons with these …

Biology of cutaneous squamous cell carcinoma

RE Kwa, K Campana, RL Moy - Journal of the American Academy of …, 1992 - Elsevier
Nonmelanoma skin cancer is the leading cause of cancer in the United States. Cutaneous
squamous cell carcinoma is second only to basal cell carcinoma in prevalence and its …

Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation

B Ensoli, L Buonaguro, G Barillari, V Fiorelli… - Journal of …, 1993 - Am Soc Microbiol
During acute human immunodeficiency virus type 1 (HIV-1) infection or after transfection of
the tat gene, Tat protein is released into the cell culture supernatant. In this extracellular …

[图书][B] Dail and Hammar's pulmonary pathology

DH Dail, SP Hammar - 2013 - books.google.com
The first edition of Pulmonary Pathology was dedicated to Vascular Diseases. Vasculitis is
so complex as to con two giants in the field, Drs. Averill Liebow and Herbert tinue to warrant …

Human immunodeficiency virus‐related lymphoma. Prognostic factors predictive of survival

AM Levine, J Sullivan‐Halley, MC Pike, MU Rarick… - Cancer, 1991 - Wiley Online Library
In an attempt to determine factors predictive of survival in patients seropositive for human
immunodeficiency virus (HIV) with acquired immune deficiency syndrome (AIDS)‐related …

HIV-related lung cancer in the era of highly active antiretroviral therapy

M Bower, T Powles, M Nelson, P Shah, S Cox… - Aids, 2003 - journals.lww.com
Objectives: To address the impact of highly active antiretroviral therapy (HAART) on the
incidence and outcome of patients with HIV-related lung cancer. Design and subjects …

Incidence of human immunodeficiency virus-related and nonrelated malignancies in a large cohort of homosexual men.

DW Lyter, J Bryant, R Thackeray, CR Rinaldo… - Journal of clinical …, 1995 - ascopubs.org
PURPOSE To determine if the rates of malignancies other than Kaposi's sarcoma (KS) and
non-Hodgkin's lymphoma (NHL) are increased in human immunodeficiency virus (HIV) …

Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1

CS Rabkin, F Yellin - JNCI: Journal of the National Cancer …, 1994 - academic.oup.com
Background: Human immunodeficiency virus type 1 (HIV-1) infection is known to increase
the incidence of Kaposi's sarcoma and non-Hodgkin's lymphoma. Parallels with other …

Gastrointestinal malignancy in patients with AIDS.

JB Danzig, LJ Brandt, JF Reinus… - American Journal of …, 1991 - search.ebscohost.com
To clarify the prevalence and characteristics of gastrointestinal malignancy in patients with
AIDS, we reviewed the demographics and clinical features of patients with AIDS and …

Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma: a prospective multi-institutional trial

AM Levine, JC Wernz, L Kaplan, N Rodman, P Cohen… - Jama, 1991 - jamanetwork.com
Objective.—To ascertain if low-dose multiagent chemotherapy, with central nervous system
prophylaxis and antiretroviral therapy, might be associated with increased efficacy and …